azelastine hydrochloride (Perrigo New York Inc)
Welcome to the PulseAid listing for the azelastine hydrochloride drug offered from Perrigo New York Inc. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
NON-PROPRIETARY NAME: | azelastine hydrochloride |
SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-04-09 |
END MARKETING DATE: | 2018-03-01 |
azelastine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | azelastine hydrochloride from Perrigo New York Inc |
LABELER NAME: | Perrigo New York Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 205.5(ug/1) |
START MARKETING DATE: | 2015-04-09 |
END MARKETING DATE: | 2018-03-01 |
PRODUCT ID: | 45802-039_a3f624ca-6cda-45d4-bd3b-f99fa7615895 |
PRODUCT NDC: | 45802-039 |
APPLICATION NUMBER: | NDA022371 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: